| mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
0.0089 |
0.9 |
| mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
17-AAG |
FIMM |
pan-cancer |
AAC |
-0.029 |
0.9 |
| mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |